GelMEDIX Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $14.3M

  • Investors
  • 5

GelMEDIX General Information

Description

Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. The company's platform focuses on bio-adhesion, tissue regeneration, tunable mechanics and therapeutic loading across modalities from small molecules to cell and gene therapies through its photo-crosslinked hydrogels, enabling medical professionals to perform cell-based therapies for vision restoration, intraocular sustained release of small molecules and peptides and in situ forming bioadhesives.

Contact Information

Website
www.gelmedix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 238 Main Street
  • Fifth Floor
  • Cambridge, MA 02142
  • United States
+1 (941)
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 238 Main Street
  • Fifth Floor
  • Cambridge, MA 02142
  • United States
+1 (941)

GelMEDIX Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GelMEDIX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 29-Apr-2026 $14.3M Completed Pre-Clinical Trials
6. Mezzanine 30-Jan-2025 Completed Pre-Clinical Trials
5. Debt - General 26-Mar-2024 Completed Pre-Clinical Trials
4. Early Stage VC (Series A) Cancelled Pre-Clinical Trials
3. Mezzanine 09-Aug-2022 Completed Pre-Clinical Trials
2. Mezzanine 28-Apr-2021 $2.35M $2.6M Completed Pre-Clinical Trials
1. Mezzanine 19-Jun-2020 $250K $250K Completed Pre-Clinical Trials
To view GelMEDIX’s complete valuation and funding history, request access »

GelMEDIX Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-2
Seed-1
To view GelMEDIX’s complete cap table history, request access »

GelMEDIX Patents

  • 24

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

GelMEDIX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024361829-A1 Acrylated gelatin polymer compositions comprising cells Pending 18-Oct-2023
EP-4794668-A1 Acrylated gelatin polymer compositions comprising cells Pending 18-Oct-2023
WO-2025085609-A1 Acrylated gelatin polymer compositions comprising cells Inactive 18-Oct-2023
JP-2026536396-A Cell-containing acrylic gelatin polymer composition Pending 18-Oct-2023
AU-2023255401-A1 Gelma polymer compositions comprising cells Pending 20-Apr-2022 A61L27/222
To view GelMEDIX’s complete patent history, request access »

GelMEDIX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GelMEDIX Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beacon Angels Angel Group Minority
Boston Harbor Angels Angel Group Minority
HTL Biotechnology PE-Backed Company Minority
Safar Partners Venture Capital Minority
TiE Angels Boston Venture Capital Minority
To view GelMEDIX’s complete investors history, request access »

Ready to get started?

Request a free trial

GelMEDIX FAQs

  • When was GelMEDIX founded?

    GelMEDIX was founded in 2020.

  • Where is GelMEDIX headquartered?

    GelMEDIX is headquartered in Cambridge, MA.

  • What is the size of GelMEDIX?

    GelMEDIX has 5 total employees.

  • What industry is GelMEDIX in?

    GelMEDIX’s primary industry is Discovery Tools (Healthcare).

  • Is GelMEDIX a private or public company?

    GelMEDIX is a Private company.

  • What is the current valuation of GelMEDIX?

    The current valuation of GelMEDIX is .

  • What is GelMEDIX’s current revenue?

    The current revenue for GelMEDIX is .

  • How much funding has GelMEDIX raised over time?

    GelMEDIX has raised $23.9M.

  • Who are GelMEDIX’s investors?

    Beacon Angels, Boston Harbor Angels, HTL Biotechnology, Safar Partners, and TiE Angels Boston have invested in GelMEDIX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process